Skip to main content
Top

Current Nutrition Reports

Issue 3/2012

Content (8 Articles)

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Gene–Diet Interactions on Lipid Levels: Current Knowledge in the Era of Genome-Wide Association Studies

Celia G. Walker, Susan A. Jebb

Open Access GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Gene-Diet Interactions on Colorectal Cancer Risk

Li-Shu Wang, Chieh-Ti Kuo, Yi-Wen Huang, Gary D. Stoner, John F. Lechner

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Gene–Diet Interactions and Obesity Indices

Constantina Papoutsakis

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Gene–Diet Interactions in Cardiovascular Disease

Maria E. Dimitriou, George V. Z. Dedoussis

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Plant Oils and Cardiometabolic Risk Factors: The Role of Genetics

Caren E. Smith

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Calcium and Vitamin D Intake Interactions with Genetic Variants on Bone Phenotype

Maria G. Stathopoulou, Efi Grigoriou, George V. Z. Dedoussis

GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Genetic Predisposition and Taste Preference: Impact on Food Intake and Risk of Chronic Disease

Cedrick D. Dotson, Jennifer Babich, Nanette I. Steinle

Open Access GENETICS (GVZ DEDOUSSIS, SECTION EDITOR)

Gene–Lifestyle Interactions in Obesity

Jana V. van Vliet-Ostaptchouk, Harold Snieder, Vasiliki Lagou

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine